facebook pixel Phone 212 693 530* *Fixed network call charges according to your tariff Search for your nearest Collection Point

212 693 530*

Collection Points

Phone 212 693 530* *Fixed network call charges according to your tariff

What is the Harmony Prenatal Test?

Harmony—The latest advancement in prenatal screening, now available in Portugal at the Germano de Sousa Group Laboratories.

Harmony represents the greatest advance in the field of non-invasive prenatal testing for the screening of the three main trisomies (T21, 18, 13) and aneuploidies related to the sex chromosomes (X and Y).

It is performed in a SIMPLE and SAFE manner using a sample of maternal peripheral blood and provides results with a high degree of ACCURACY.

Harmony uses a technology (DANSR™) that analyzes fragments of cell-free fetal DNA circulating in the mother’s blood; this direct analysis method is what gives the test its high accuracy and reliability as a screening test.

The Germano de Sousa Laboratory Medicine Center, drawing on its extensive experience of more than 10 years in prenatal screeningscreening and in collaboration with all other laboratories in the Germano de Sousa Group, has maintained a partnership since 2013 with Ariosa Diagnostics, Inc. (San Jose, CA, USA), the developer of Harmony.

The test is endorsed by the Fetal Medicine Foundation (U.K.), the world’s leading authority in the field of maternal-fetal medicine and research, directed and coordinated by Prof. K. Nicolaides.

As a result, the non-invasive prenatal screening test—which offers the highest detection rates (>99%) for the major trisomies—is now available to all pregnant women starting at 10 weeks of gestation.

The implementation of this test will lead to a very significant reduction in the false-positive rate (< 0.1%) and in the need for invasive procedures (currently, about 50 out of every 1,000 pregnant women undergo amniocentesis or chorionic villus sampling as a result of current screening tests; this number will drop to less than 1 out of every 1,000 pregnant women).

The adoption of this test by obstetricians and pregnant women will represent a giant leap forward in obstetric practice, as they will now have access to a 100% safe method, with absolutely no risk to their baby and detection rates very close to those of conventional diagnostic methods (amniocentesis and chorionic villus sampling) of >99%.

 

Harmony Prenatal Screening with Optional Chromosomal Sex Aneuploidy Panel

 

To screen for the major trisomies (21, 18, and 13) and also assess the copy number for both the X and Y chromosomes, which allows for the assessment of the risk of sex chromosome aneuploidies (XO, XXY, XXX, XYY, XXYY)

Fetal sex information will only be provided if requested separately, at no additional cost. 

In less than 0.5% of cases, it is not possible to obtain a result for the analysis of the X and Y chromosomes. There are many possible reasons for this. Technical reasons include high variability in sequencing counts. Biological reasons may include mosaicism (maternal, fetal, or placental), loss of one twin, or copy number variants. In the case of a biological cause, such as maternal mosaicism, a result is not expected following repeat analysis.

As with the other conditions included in the Harmony test, the X,Y test is not diagnostic of aneuploidy. All results indicating a high risk for X,Y aneuploidy should include a recommendation for genetic counseling and additional invasive testing (BVC/amniocentesis).

 

New: Harmony® Prenatal Screening with X Monosomy Option

It is now possible to request the X Monosomy (Turner Syndrome) option separately. This option will assess the risk for the major trisomies (21, 18, and 13) and evaluate the risk of X monosomy, or Turner syndrome (XO).

This option does not include risk assessment for other sex chromosome aneuploidies.

Fetal sex information will not be provided unless requested separately, at no additional cost.

As with the other conditions included in the Harmony test, the X,Y test is not diagnostic of the presence of an aneuploidy. All results indicating a high risk for X,Y aneuploidy should include a recommendation for genetic counseling and additional invasive testing (BVC/amniocentesis).

 

Twins

Harmony® Prenatal Screening is validated for twin pregnancies.

Limitations of the test for twin pregnancies are:

· The result for T21, T18, and T13 is a single result for both fetuses; that is, whether the test result is low risk or high risk applies to both fetuses.

· The Harmony X,Y or XO test cannot be ordered. (see acceptance criteria) 

· It cannot be performed for multiple pregnancies with more than 2 fetuses.

NEW: The fetal sex option is available for twin pregnancies. In twin pregnancies, the fetal sex result is a single result; therefore, a “male” result indicates one or two male fetuses.

If you have any questions, please contact us.
We'll be happy to help.

CLINICAL PATHOLOGY LABORATORY

CLINICAL PATHOLOGY LABORATORY
EMAIL

Phone 212 693 530*

*Fixed network call charges according to your tariff

Related articles: